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Abstract 
 
Introduction: Surgical complications are a major disincentive to transplantation despite 
the undisputed benefits of restored organ function. Robot-assisted surgery is the new 
technological advance of the recent years. The da Vinci surgical system, a computer 
assisted electromechanical device, provides the unique opportunity to test whether 
laparoscopy can reduce the morbidity in the setting of transplantation. We evaluate the 
feasibility and safety of this new surgical technique in living kidney donation, kidney 
transplantation and pancreas transplantation. 
Materials and methods: Robot assisted living donor nephrectomy was performed on 2 
subjects. The immediate post-operative courses for these donors, and their respective 
recipients, were compared with those of 20 laparoscopic living donor nephrectomies, 
performed in the same period. Moreover robot assisted kidney transplantation was 
performed on 2 living kidney recipients and robot assisted laparoscopic pancreas 
transplantation was performed in further 3 recipients, performing a pancreas after 
kidney transplant, a simultaneous pancreas kidney transplantation, and a pancreas 
transplant alone. The grafting procedures were carried out through an 11 mm optic 
port, two 8 mm operative ports, and a 7 cm incision (midline for pancreas and 
suprapubic for kidney). The latter was used to introduce the grafts, handle vascular 
crossclamping, and create pancreas exocrine drainage into the jejunum or uretero-
vescical anastomosis in case of kidney transplant. 
Results: No significant differences between the two donor groups with respect to age, 
gender, body mass index or renal vasculature were found. The average operative 
times and the warm ischaemia times were similar. There was no conversion to open 
surgery in both groups. The estimated blood loss was slight. Following nephrectomy, 
no complication occurred. The average duration of hospitalization was similar. The 
estimated creatinine clearance rate was equivalent for all donors, at 5 days and 1 
month after nephrectomy. All kidneys started functioning immediately after the 
transplantation. The mean recipient estimated creatinine clearance was similar. Two 
kidneys, one from a 56-year-old mother to her 37-year-old daughter and one from a 49-
year-old sister to her 48-year-old brother were transplanted laparoscopically using the 
DaVinci surgical system. Vascular anastomoses were carried out through a total of 
three additional ports. Surgery lasted 154 and 148 min, including 51 and 39 min of 
warm ischemia of the graft, respectively. Urine production started immediately after 
graft reperfusion. Renal function remains optimal at the longest follow-up of 10 and 3 
months. The two solitary pancreas transplants lasted 3 and 5 hrs, respectively, the 
simultaenous pancreas kidney transplantation lasted 8 hrs. Mean warm ischemia time 
of the pancreas graft was 34 minutes. All pancreata functioned immediately, making 
their recipients insulin-independent. The kidney graft, revascularized after 35 minutes 
of warm ischemia, also functioned immediately and fully. No patient had complications 
during or after surgery; mean hospital stay was 21 ±5 days. After a mean follow-up 
period of 3.7 months, all recipients are alive with optimal graft function. 
Conclusion: Robotic assisted living donor nephrectomies were associated with no 
morbidity among donors, in which both the operative and warm ischaemia times were 
no longer duration, moreover had no observable adverse effects upon short-term graft 
function. On the other hand the daVinci surgical system allows the performance of 
kidney transplantation under optimal operative conditions. Further experience is 
needed, but it is likely that solid organ transplantation will not remain immune to 
robotics. We have also shown the feasibility of laparoscopic robot-assisted solitary 
pancreas and simultaneous pancreas and kidney transplantation. If the safety and 
feasibility of this procedure can be confirmed in larger series, laparoscopic robot 
assisted pancreas transplantation could become a new option for diabetics needing 
beta-cell replacement. 
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Introduction 
 
Live kidney donation is an important alternative for patients with end-stage renal 
disease. Renal transplantation from living donors confers several advantages 
as compared with dialysis and transplantation from deceased donors, including 
improved longer-term patient survival, better quality of life, immediate 
functioning of the transplant, better transplant survival, and the possibility of 
transplanting pre-emptively (1–9). 
To date, the health of live kidney donors at longterm follow-up is good, and the 
procedure is considered to be safe (2). Currently, attention to donor wellbeing 
has become a priority, and therefore the surgical technique must be optimized 
continually. The surgical practice has evolved from the open lumbotomy, 
through mini-incision muscle-splitting open (mini-incision open donor 
nephrectomy; MIDN), to minimally invasive laparoscopic techniques. There are 
different minimally invasive techniques, including standard laparoscopic, hand-
assisted laparoscopic, hand-assisted retroperitoneoscopic, pure 
retroperitoneoscopic, and robotassisted live donor nephrectomy. At present, 
these minimally invasive techniques are being subjected to clinical trials 
focusing on surgical outcome, quality of life, costs, long-term follow-up, and 
morbidity of donor, recipient, and graft. 
Other issues that surgeons encounter with live kidney donation are related to 
the type of kidney to select, the factors to be reckoned while dealing with obese 
donors, and the strategies to be adapted while approaching donors with multiple 
arteries and veins. Many centers still restrict donor nephrectomy to relatively 
younger, normal weight donors, categorized as American Society of  
Anaesthesiologists group I. They tend to choose the left kidney, with simple 
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renovascular anatomy. Nowadays, donors with isolated abnormalities, i.e. 
hypertension or obesity, can also be accepted for live kidney donation, as 
longterm renal function and health is good. 
Open nephrectomy is the accepted standard procedure for live donor kidney 
removal (10), but attempts are now being made to duplicate the outcomes of 
this traditional open donation method with less invasive surgical techniques. 
Laparoscopic nephrectomy has recently gained popularity as it provides the 
potential advantages of decreased post-operative pain, shorter hospital stay 
and faster recuperation (11, 12). However, the surgical techniques required for 
this procedure are demanding, extremely difficult to master (13) and, 
consequently, have been adopted by only a few centres. Modifications such as 
hand-assisted techniques, and more recently, robotic assistance, have been 
suggested to improve surgical outcomes. 
The robotic system provides steady imagery with threedimensional visualization 
and additional degrees of freedom that mimic human wrist motions, and 
eliminate both exaggerated hand motions and fine tremors (14, 15). To our 
knowledge, no reports are currently available regarding laparoscopic donor 
nephrectomy performed completely with the assistance of a robot, especially 
without the conjunction of a hand-assisted procedure (16), and there have been 
no observations made on either donor safety or the quality of the recovered 
organ with this approach. For robotic assisted living donor nephrectomy to 
become a viable option for procuring kidneys for renal transplantation, it is 
essential that the donor suffers no additional morbidity and that the prognosis 
for recipients should be at least equivalent to the ‘gold standard’ of open 
nephrectomy. In this regard, open live-donor nephrectomy sihas proven to be 
very safe for donors, with reported mortality rates of between 0.03–0.06%, and 
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the transplanted kidney is usually of excellent quality following this procedure 
(10). 
The technique for kidney transplantation (KT) has evolved little since 1950s 
(17). Rosales et al. recently reported on a patient undergoing successful 
laparoscopic KT (18). Although this case report shows that a kidney can be 
transplanted laparoscopically, it does not demonstrate that this operation can be 
reliably duplicated by the average transplant surgeon. Laparoscopy is indeed 
used infrequently in operations requiring multiple vascular anastomosis 
because of loss of hand–eye coordination, use of long instruments amplifying 
natural surgeon’s tremor and carrying a fulcrum effect, and poor ergonomy 
causing surgeon’s fatigue (19). The daVinci™ SiHD surgical system (dVss) 
(Intuitive Surgical, Sunnyvale, CA, USA) is a computer-assisted 
electromechanical device acting as a remote telepresence manipulator 
controlled by a surgeon (20). The dVss provides the operating surgeon with 3D 
high-definition view including 10 to 15·magnification, fully restoring hand–eye 
coordination; it employs wristed instruments, with seven degrees of freedom, 
and it tracks surgeon’s movements 1,300 times/s, providing for tremor filtration 
and scaled motion. Furthermore, the surgeon simultaneously drives the 
binocular endoscope, achieving steady view, and toggles between three 
operative arms (21). These features translate into significant operative 
advantage, especially when the operative field is deep and narrow, and when 
fine dissection and microsuturing are required (21). The dVss is currently used 
in urology, for radical prostatectomy, pyeloplasty, and ureteral reimplantation 
(20), as well as in vascular surgery for coronary artery by-pass (22), repair of 
renal artery aneurysm (19), and repair of abdominal aorta (23). Thus, it would 
seem that the dVss could facilitate the implementation of laparoscopy in KT. 
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Vascularized pancreas transplantation is the only treatment that routinely and 
consistently restores endogenous, servo-regulated, insulin secretion making 
beta-cell-penic diabetic patients euglycemic (24). The main penalties for insulin 
independence are operative risk (24, 25) and need for chronic 
immunosuppression(26, 27). 
Despite recent improvements, pancreas transplantation continues to have the 
highest rate of surgical complications among all kinds of solid organ 
transplantation (25). The intrinsic fragility of diabetic recipients further 
compounds operative risk (28). A reduction of post-transplant morbidity would 
be very much welcome and could possibly make pancreas transplantation a 
more appealing treatment option for selected diabetic patients. 
As compared with conventional operations, laparoscopy is associated with 
reduced pain, earlier recovery, quicker return to daily life activities, lower 
incidence of wound complications, and better cosmetic result (29, 30). Until 
recently, however, laparoscopy was not deemed suitable for organ 
transplantation. Experience in several abdominal (31, 32) and thoracic 
operations(33) shows that robot-assistance greatly enhances surgeon’s power 
in endoscopic operations, especially when fine dissection and microsuturing are 
required (34). Based on these backgrounds, few groups, including our own, 
have successfully performed laparoscopic, robot-assisted, renal transplantation 
(35, 36). 
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Aim of the Study 
 
Robot-assisted surgery is the new technological advance of the recent years. The 
applicability and safety of this new surgical technique to the settings of 
transplantation procedures is not still assessed. In this study It is evaluated the 
application of the robot-assisted laparoscopic approach to living kidney 
donation, kidney transplantation and pancreas transplant settings. 
Robot-assisted living donor nephrectomy was planned and performed. Data 
regarding perioperative morbidity and mortality of the donors and early 
outcomes of the recipients were analyzed. Results were then compared with 
similar data obtained from most recent laparoscopic living donor nephrectomies, 
where the same surgical team had performed both procedures of harvesting 
and transplantations. 
Robot-assisted laparoscopic approach was applied to what we believe to be the 
first two European cases of robotic kidney transplantation, presenting the 
technique we have employed, it is evaluated the safety and feasibility and it is 
discussed the pros and cons of the use of this new technology in kidney 
transplantation. 
Morover, robot-assisted laparoscopic approach was applied to the world first 
three whole pancreas transplants performed laparoscopically with the 
assistance of the dVss, evaluating feasibility and safety of the procedure. 
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Materials and methods 
 
ROBOTIC ASSISTED LIVING DONOR NEPHRECTOMY 
Kidney donors and recipients  
In Pisa live donor nephrectomy for living kidney transplantation started in 1972. 
From 1972 to March 2000 live kidney donor nephrectomy was exclusively 
performed by open surgery and resulted in 58 living kidney transplantations. 
Since April 2000, live kidney donors have been presented with every possible 
surgical option at Pisa transplantation center facility and have consistently 
chosen the laparoscopic technique. Thus, between April 2000 and October 
2008, 110 laparoscopic living donor nephrectomies and 34 open living donor 
nephrectomies were performed at Pisa transplant centre. 
In November 2008 the robot-assisted laparoscopic donor nephrectomy option 
was introduced at Pisa transplant centre and in the next 18 months (November 
2008-May 2010) applied it to 2 donors. The clinical course of these latter 
individuals, and of the corresponding recipient patients, was compared with 20 
laparoscopic live-donor nephrectomies which had been performed in the same 
period.  
 
Pre-operative donor evaluation 
Patient evaluation for robot assisted living donor nephrectomy was similar to the 
evaluation method used for laparoscopic donor operations. Potential candidates 
for donor nephrectomy underwent a standard pre-operative evaluation by our 
transplant division. The presence of two functional kidneys and the assessment 
of vascular anatomy were determined by multi-slice spiral computed angio-
tomography. Standard arteriography only if either the computed tomographic 
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angiography results were equivocal or if renal artery dissecative or occlusive 
disease was suspected. 
 
Surgical technique 
All the live donor nephrectomy procedures have been performed with the 
patient positioned in the dorsal decubitus position, ipsilateral side lifted up and 
table rotated 45 degrees axially in order to bring the patient in a lateral kidney 
position. General anaesthesia is routinely used. 
Laparoscopic nephrectomies were done in different way according to the side of 
the removed kidney, 1 surgeon and 2 surgical assistants were involved in the 
procedures. In case of left kidney laparoscopic living donor nephrectomy it was 
used a pure laparoscopic approach with 3 trocars (1 optical and 2 operatives) 
for mobilization of the kidney, of the ureter and for dissection of the vessels. 
Then the kidney graft was removed after been loaded on a Endocatch bag 
(Ethicon s.p.a., Pomezia, Italy) through a Pfannestiel incision. In case of right 
kidney laparoscopic living donor nephrectomy an hand assisted laparoscopic 
approach was applied using 2 trocars (1 for the optical device and 1 operative) 
combined with a 7 cm midline upper umbilical incision in which a Gelport TM 
laparoscopic system (Applied Medical, Rancho Santa Margarita, CA, USA) was 
placed for the introduction of left hand of the surgeon. This approach was used 
for: kidney mobilization, vessels dissection and kidney graft extraction. In both 
cases the peritoneal cavity was insufflated with carbon dioxide to a pressure of 
12 mmHg and the urine output was maintained throughout the surgery by 
administering intravenous fluids. At the critical point of ligature and section of 
the vessels, an additional surgeon was available to facilitate the removal and 
rapid flushing of the kidney. The organ was extracted alternatively through the 
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Pfannenstiel incision or the service incision for the hand, using an entrapment 
sac, placed on ice and flushed with cold heparinazed Ringer Lactate solution 
Robotic assisted live donor nephrectomy procedures are performed completely 
robotically, using the dVss. The surgeon is seated at a remote console, once 
the robotic arms are docked to the trocars. One surgical assistant is stationed at 
the operating table to perform suction-irrigation, assist with instrument 
exchanges, introduce and remove suture material and apply sutures to the renal 
vessels. The procedure then follows a transperitoneal approach. The peritoneal 
cavity is insufflated with carbon dioxide to a pressure of 12 mmHg and the urine 
output is maintained throughout the surgery by administering intravenous fluids. 
At the critical point of ligature of the vessels, an additional surgeon is available 
to facilitate the removal of the kidney. The organ is extracted through a 
Pfannenstiel incision, using an entrapment sac, placed on ice and flushed with 
cold heparinazed Ringer Lactate solution. 
The principle of leaving a healthier and better-functioning kidney with the donor 
was also adopted in every case and the left kidney was used preferentially for 
technical reasons. In cases involving two or more renal arteries, vascular 
reconstruction was performed before implantation to the recipient vessels. All 
the donors received calcium heparin for thromboprophylaxis for 2 weeks after 
their nephrectomy, irrespective the surgical technique applied.  
 
Recipient evaluation and transplantation 
Patients were selected for transplantation based on established evaluation 
criteria. Organ recipients underwent surgery in an adjacent operating theatre. In 
all cases, the transplantation was performed in a standard fashion. Ureteral 
implantations were performed according to the method described by Gregoire 
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and Lich, and double J ureteral stents were routinely used. The patients 
received standard regimens of immunosuppressive agents, which included tri-
therapy based on an inhibitor of calcineurin (tacrolimus) with mycophenolate 
mofetil and prednisone. Antibody induction was also used alternatively with 
basiliximab or thymoglobulin. A Doppler ultrasound was systematically 
performed during the first 48 h and once a week during the first month post-
transplantation. 
 
Patient parameters 
The charts of each of the 20 donors and the 20 corresponding recipients 
incorporated into this study were prospectively analyzed. The donor parameters 
that were assessed included surgical data, operative times, warm ischaemia 
times, blood loss, intra-operative complications, post-operative complications, 
length of hospital stay and renal function. Creatinine clearances were estimated 
utilizing the Cockroft– Gault formula and changes of clearances on the first five 
post-operative days and on the first month were calculated. Intra-operative 
blood loss was estimated by the decrease in haemoglobin levels at 24 h 
following nephrectomy. Donors in both groups were discharged home when 
they were free of post-operative complications and spontaneous pains. For the 
recipients, data about the necessity for dialysis during the first week after 
transplantation as well as serum creatinine levels on days 1, 2, 3, 4 and 5 after 
transplantation were collected. Early evolution of renal function was investigated 
by the measurement of the creatinine reduction ratio (CRR2) from post-
transplantation day 1 to day 2. 
The formula to define CCR2 was: 
CRR2 (%) = (Cr1 - Cr2) x 100 / Cr1, 
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where Cr1 and Cr2 are serum creatinine values on posttransplantation day 1 
and day 2, respectively. Any immediate post-operative complications were also 
noted. 
 
Statistical analysis 
Data are presented as the mean±SD. Statistically significant differences 
between the laparoscopic living donor and robotic assisted living donor groups 
were analysed by utilizing the chi-square or Student’s t-test for parametric data 
and the Mann–Whitney rank sum test for non-parametric data, with a P-value of 
<0.05 considered significant. 
 
ROBOTIC ASSISTED KIDNEY TRANSPLANTATION 
Recipients 
Recipient 1 she was a 37-year-old Caucasian woman on dialysis since 32 
months because of lupus nephritis. She was 164 cm tall and weighed 59 kg. 
Her surgical history included hysterectomy, performed through a Pfannenstiel 
incision. On July 3, 2010 she received a left kidney from her mother, a 56-year-
old woman. The graft had no vascular or urologic variations and was procured 
laparoscopically. It was perfused with cold Celsior solution and was 
transplanted after 58 min of cold storage. 
Recipient 2 he was a 48-year-old Caucasian man on dialysis since 24 months 
because of glomerulonephritis. He was 182 cm tall and weighed 73 kg. His 
surgical history was negative. On February 15, 2011 he received a left kidney 
from her sister, a 49-year-old woman. The graft had no vascular or urologic 
variations and was procured laparoscopically. It was perfused with cold Celsior 
solution and was transplanted after 38 min of cold storage. 
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Surgical technique 
The patient was positioned supine, with the right flank slightly elevated, and was 
secured to the operating table using wide bandings (Figure 1a). The table was 
then tilted 25° to the left, further elevating the right flank, and 15° in 
Trendelenburg’s position. A 7-cm suprapubic incision was made along the 
previous Pfannenstiel incision where a hand access device was inserted (Lap 
DiscTM; Ethicon spa, Pomezia, Italy). 
Figure 1a: Operative position. Dotted line marks the previous Pfannestiel incision. 
 
Through a 12-mm port, placed within the lap disk, pneumoperitoneum was 
created at a pressure of 12 mmHg. Under laparoscopic view, an 11 mm port, to 
be used for the endoscope, was placed slightly to the left of the mid-line and 
some centimeters below the navel, and an 8 mm robotic port was placed along 
the right pararectal line some 5 cm below the costal margin. A final port (12 
mm), to be used by the assistant surgeon at the table, was placed along the left 
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pararectal line halfway between the Pfannenstiel incision and the camera port 
(Figure 1b).  
Figure 1b: Lap Disk and operative ports in place. Port number 2 is used by the 
assistant surgeon at the table. Port number 3 is used for the optics. Port number 4 is 
used for the right robotic arm. While the DaVinci surgical system is functioning a 
further port, used for the left robotic arm, is hel in place by the Lap Disk.. 
 
 
The dVss, placed to the patient’s right side, was docked into position (Figure 
1c) and a 0° endoscope was advanced through the 11 mm  port. Two operating 
arms were used. The distal robotic arm operated through a port placed within 
the suprapubic lap disk. The operation began by mobilizing the cecum until the 
common iliac vessels were exposed (Figure 2a). Lymphatics were individually 
ligated and cut. Dissection was carried out using either bipolar Maryland forceps 
or micro bipolar forceps on the left robotic arm, and monopolar curved scissors 
on the right robotic arm (Figure 3). Iliac vessels were then crossclamped using 
laparoscopic bulldogs and the kidney was pushed into the abdomen through the 
Pfannenstiel incision and dragged over the right psoas muscle using a Cadiere  
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Figure 1c: DaVinci surgical system docked in the operative position. 
 
 
Figure 1c: DaVinci surgical system docked in the operative position. 
Figure 2: (a) Common iliac vessels exposed; (b) Venotomy being made using Potts 
scissors; (c) Venous anastomosis being made using black diamond micro forceps and 
De Backey forceps; (d) Arterial anastomosis being made using black diamond forceps 
and De Backey forceps; (e) Venous anastomosis after graft reperfusion; (f) Arterial 
anastomosis after graft reperfusion. 
 
 
forceps. The left robotic arm was re-docked and armed with DeBackey forceps 
and the right-one with Potts scissors. After creating a venotomy (Figure 2b), the 
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renal vein was anastomosed end-to-side to the common iliac vein using two half 
running sutures of 6–0 expanded polytetrafluoroethylene using black diamond 
micro forceps on the right robotic arm and DeBackey forceps on the left-one 
(Figure 2c). The same steps were followed to create an end-to-side arterial 
anastomosis between the renal artery and the common iliac artery (Figure 2d). 
Figure 3: Drawing depicting the full set of robotic instruments used for kidney 
transplantation. The central drawing, within the circle, shows the range of motion of 
wristed robotic instruments. (a) Cadiere forceps; (b) fenestrated Maryland bipolar 
forceps; (c) micro bipolar forceps (d) monopolar curved scissors; (e) large needle 
driver; (f) black diamond micro forceps; (g) De Backey forceps; (h) Potts scissors.. 
 
 
 
ROBOTIC ASSISTED PANCREAS TRANSPLANTATION 
Setting. 
Pancreas transplantation was the last step of this feasibility and safety study 
regarding the application of the robotic assisted surgery to transplantation 
procedures. It was developed in the context of a multidisciplinary team having 
39 years of experience in transplantation of abdominal organs. Surgery and 
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anesthesia teams, in particular, have extensive experience in whole pancreas 
transplantation and advanced laparoscopic procedures, including laparoscopic 
robot-assisted auto- and allo-transplantation of the kidney (36). All modern 
laparoscopic technologies are available at our Institution and the laparoscopic 
robot-assisted transplant, using the last generation of dVss was proposed to the 
candidate recipients, who were informed of the innovative nature of the 
procedure and gave a written consent. 
 
Donor selection, graft procurement and back-table preparation. 
A summary of donors’ characteristics is provided in Table 1. Deceased donors 
were selected according to standard criteria, as previously described (37). On 
the contrary, departing from our institutional policy of quick en-bloc procurement 
of abdominal organs (38), the grafts planned for robotic transplantation were 
fully dissected before aortic crossclamping. This decision was based on the 
willingness to ensure hemostasis in the donor, thus reducing the possibility of 
graft bleeding after reperfusion, which might be difficult to control 
laparoscopically. Vascular pedicles of the pancreas graft were dissected out, 
but they were not ligated or divided until completion of visceral perfusion. Grafts 
were perfused through an aortic cannula with University of Wisconsin solution 
(60 ml/kg) by gravity flush from a height of 80 centimetres. Direct portal 
perfusion of the liver was avoided. 
At the back table, a donor Y iliac arterial graft was joined to graft arterial 
pedicles, in a standard fashion (38). No further graft preparation was needed. 
The left kidney, used for the simultaneous pancreas-kidney transplantation, was 
not further checked at the back table since it had been procured as in a live 
donor operation. 
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Table 1: Summary of donor characteristics. 
 
  Donor 1 
(for recipient 1) 
 Donor 2 
(for recipient 2) 
 Donor 3 
(for recipient 3) 
       
Age  48 years  16 years  25 years 
Sex  Female  Male  Female 
Body Mass Index  20.9 Kg/m
2
  20.8 Kg/m
2
  22.5 Kg/m
2
 
Waist circumeference  83 cm  78 cm  72 cm 
       
Cause of death  Cerebrovascular 
accident 
 Trauma  Trauma 
ICU stay  11 days  3 days  2 days 
       
Cardiac arrest  Yes  No  No 
Duration of cardiac 
arrest 
 20 min  -  - 
Hypotension at 
procurement 
 No  No  No 
Vasopressors  Yes  Yes  No 
 Noradrenaline  Yes  Yes  No 
 Dopamine  Yes  No  No 
       
CMV matching 
(donor/recipient) 
 Positive/Positive  Positive/Positive  Positive/Positive 
     
 
 
Recipients 
A summary of recipient characteristics is provided in Table 2. All patients had a 
long lasting history of type 1 diabetes. 
Recipient 1 (pancreas after kidney), who had previously received a renal 
transplantation from a deceased donor into her left iliac fossa, had an estimated 
creatinine clearance of 55 ml/min under a triple maintenance 
immunosuppression regimen including tacrolimus, mycophenolate mofetil and 
steroids. She had also undergone hysterectomy, through a Pfannienstel 
incision, because of uterine fibromata. 
Recipient 2 (simultaneous pancreas-kidney) had chronic hepatitis B (HBV-
DNA 26.600 IU/ml), without HDV superinfection. 
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Table 2: Summary of recipient characteristics. 
 
  Recipient 1  Recipient 2  Recipient 3 
       
Type of  transplant  Pancreas after 
kidney 
 Simultaneous 
pancreas and 
kidney 
 Pancreas 
alone 
Age  43 years  24 years  53 years 
Sex  Female  Male  Female 
Ethnicity  Caucasian  Caucasian  Caucasian 
Body Mass Index  26.4 Kg/m
2
  23.7 Kg/m
2
  20.8 Kg/m
2
 
       
Duration of diabetes  18 years  20 years  28 years 
Serum C peptide  0.28 ng/mL  0.33 ng/mL  0.22 ng/mL 
Daily insulin dose  32 UI  50 UI  35 UI 
Glycated hemoglobin  10.5%  10.8%  7.8 % 
Anti-IA2 Ab (≤ 0.75)  0.70  0.68  0.96 
Anti-GAD Ab (≤ 0.90)  0.25  0.35  0.12 
       
Diabetic nephropathy  Previous renal 
transplant 
 Chronic dyalisis  No 
Retinopathy   Proliferative  Proliferative  Proliferative 
Autonomic neuropathy  Severe  Mild  Severe 
Unawareness 
hypoglycemia 
 No  No  Yes 
       
HLA class I Ab (luminex)  10%  Negative  Negative 
HLA class II Ab (luminex)  Negative  Negative  Negative 
     
 
 
Recipient 3 (pancreas transplant alone) had no further associated morbidities 
in addition to the ones presented in Table 2. 
Immunosuppression and perioperative care were carried out in all recipients 
according to our standard protocol, as described previously (39). 
 
Robotic transplants. 
The operations followed a precisely established step-by-step protocol. 
The operating table was equipped with a heating blanket and CO2 heater. 
Anesthesia was induced using fentanyl (0.2 mg), sodium thiopental (3mg/kg) 
and atracurium besilate (0.2 mg/kg), and it was maintained using sevofluorane 
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in a 50% air oxygen low flow (2L/min) respiratory mixture delivered by a 
volumetric ventilator. Atracurium besilate was used in a continuous infusion 
(0.01 mg/kg/min) to achieve the necessary neuromuscular blockade. 
Intraoperative hemodynamic monitoring included ECG, mean arterial pressure, 
and central venous pressure. Respiratory monitoring included end tidal CO2 and 
pulse O2 levels. 
Patients were positioned supine, with the right flank slightly elevated, and were 
secured to the operating table using wide bandings. The table was then tilted 25 
degrees to the left, further elevating the right flank. A 7 centimetres midline 
incision was made just above the navel and a hand access GelPortTM device 
was inserted.  
Through a 11 mm port, placed within the GelPortTM, pneumoperitoneum was 
created at a pressure of 12 mmHg. Under laparoscopic view an 11 mm port, to 
be used for the endoscope, was placed slightly to the left of the mid-line some 
centimeters below the navel. Two 8 mm robotic ports were placed along the 
right pararectal line some 5 centimetres below the costal margin and 3 
centrimetres above the pubis, respectively(Figure 4). 
The dVss, placed to the patient’s right side, was docked into position and a 30° 
endoscope was advanced through the 11 mm optic port (Figure 5). 
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Figure 4: GelPort and trocars in place. 
 
 
 
Figure 5: DaVinci Surgical System docked to the operative ports. 
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The operation began by mobilizing the ascending colon until the common iliac 
artery and the proximal segment of the inferior vena cava were exposed. 
Lymphatics were individually ligated and cut. Dissection was carried out using 
either bipolar Maryland forceps or micro bipolar forceps on the left robotic arm, 
and monopolar curved scissors on the right robotic arm. Following intravenous 
injection of 5000 units of sodium heparin, the iliac artery was crossclamped and 
the inferior vena cava was partially occluded using bulldog clamps, manually 
applied through the GelPortTM. The graft was hence introduced through the 
hand port access and placed over the psoas muscle. After excising a 
longitudinal segment of vena cava, donor portal vein was anastomosed end-to-
side to recipient inferior vena cava using two half running sutures of 7-0 
expanded polytetrafluoroethylene (Figure 6a). Next, the arterial anastomosis 
was created, using 6-0 expanded polytetrafluoroethylene, between donor Y 
graft and recipient common iliac artery (Figure 6b). The posterior wall of 
vascular anastomoses was sutured from within the lumen (40). 
After graft revascularization, (Figure 6c) the pneumoperioneum was interrupted 
and exocrine drainage was handled, working through the hand port access, by 
means of Roux-en-Y duodeno-jejunostomy as previously described (39). At the 
end, the operative field was inspected and two close suction drains were placed 
along the graft. 
In the simultaneous pancreas-kidney transplant, the kidney was transplanted in 
the ipsilateral iliac fossa (41), according to the technique previously described 
for robotic kidney transplantation (36). The uretero-vesical anastomosis 
(Gregoir-Lich extravesical anastomosis) was performed manually, after 
converting the suprapubic robotic port access into a mini-incision approximately 
3 centimetres long. 
 24
 
Figure 6: (a) Venous anastomosis completed; (b) Arterial anastomosis completed; (c) 
Pancreas graft few minutes after reperfusion. 
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Results 
 
ROBOTIC ASSISTED LIVING DONOR NEPHRECTOMY 
Patient demographics 
Table 3 shows the pre-operative characteristics of donors and corresponding 
recipients for the two types of nephrectomy under review. There were no 
significant differences in age, gender or body mass index between the robotic 
assisted and laparoscopic groups. There was no significant dialysis duration 
difference in the recipients who did not receive a pre-emptive transplant (22.2 ± 
24.6 months in the robotic assisted group and 36.6 ±72.5 months in the 
laparoscopic group, P=NS). 
 
Table 3: Summary of living donor and recipient demographics. 
 
  Robotic Assisted  Laparoscopic  P value 
       
Donor (n)  2  20  - 
    Mean Age (years – dev std)  60,0 ±7,1  54,3 ±7,7  NS 
    Male/Female (n)  1 / 1  8 / 12  NS 
    Mean BMI (Kg/m
2
)  25,6 ±2,5  24,7 ±2,8  NS 
    Relation to the recipient       
        Sibling  1  2  - 
        Parent  0  11  - 
        Other relatives  0  1  - 
        Spouse  1  6  - 
    HLA mismatch (n –dev std)  3,4 ±1,1  2,1 ±2,1  NS 
Left/Right kidney (n)  1 / 1  15 / 5  NS 
Multiple arteries (%)  0  5%  NS 
       
Recipient       
    Mean Age (years)  41,3 ±8,2  43,2 ±7,9  NS 
    Male/Female (n)  1 / 1  14 /6  NS 
    Mean BMI (Kg/m
2
)  24,6 ±2,1  24,9 ±2,4  NS 
    Preemptive transplant (%)  0  20%  NS 
    Retransplant (%)  0  10%  NS 
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Intra-operative variables among donors (Table 4)  
The left kidney was procured from all donors with only one exception. The 
indication of the single right nephrectomy performed in the robotic assisted live 
donor group was an anomaly in the right ureter. The vascular complexity 
between the two groups was similar and the median number of ipsilateral veins 
is 1 in both cases. Mean operative times and warm ischaemia times, however, 
were not significantly longer in the robotic assisted live donor group. 
 
Table 4: Intraoperative and postoperative recovery data from live donors. 
 
  Robotic 
Assisted 
(n=2) 
 Laparoscopic 
(n=20) 
 P value 
       
Left/Right kidney (n)  1 / 1  15 / 5  NS 
N° of renal arteries (% - n°)       
    1  2  19  NS 
    2  0  1  NS 
Operative time (min)  102.5 ±18.2  133.4 ±24.5  NS 
Warm ischemia time (sec)  92.4 ±12.2  84.3 ±16.2  NS 
Mean decrease in post-op Hb (g/l)  9.7 ±7.6  10.6 ±8.4  NS 
Mean length of stay (days)  4.8 ±1.8  5.8 ±2.1  NS 
Mean plasma potassium at day 1 (mEq/l)  3.8 ±0.18  4.1 ±0.5  NS 
Mean blood urea nitrogen at day 1 (g/l)  0.2 ±0.08  0.2 ±0.05  NS 
Mean ClCr0-ClCr5 (ml/min)  21.1 ±14.9  26.2 ±12.2  NS 
Mean [(ClCr0-ClCr5)/ClCr0]x100 (%)  24.4 ±15.8  27.0 ±12.4  NS 
Mean ClCr0-ClCr30 (ml/min)  25.3 ±15.1  22.1 ±12.7  NS 
Mean [(ClCr0-ClCr30)/ClCr0]x100 (%)  24.7 ±14.6  22.8 ±13.0  NS 
     
ClCr0, ClCr5 and ClCr30 = creatinine clearance at day 0, 5 and 30 after nephrectomy 
 
Intra-operative complications in donors  
No complications were noted in both group donors and intraoperative 
conversion from laparoscopic to open surgical nephrectomy has not been 
necessary in any cases. Blood transfusions were also not required and the 
mean decreases in post-operative haemoglobin levels were minimal in both 
groups. Symptomatic pneumothorax, and bowel injury were not experienced in 
this series. 
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Post-operative courses for live donors  
There were no fatalities in either group of donors following nephrectomy and 
any morbidity was recorded in both groups. There were no cases of re-
exploration, incisional hernia, wound infection and pneumonia among patients 
of either group. Oral intake was resumed within the first 24 h in both the robotic 
assisted and laparoscopic donors. The duration of hospitalization was similar in 
both groups. The mean pre-operative estimated creatinine clearance was 
92.16±40.67 ml/min in the robotic assisted live donor group and 89.46±25 
ml/min in the laparoscopic group (P=NS). Furthermore, the mean decrease in 
creatinine clearance levels, compared with the pre-operative values, was the 
same for all donors: 24.4%, 5 days after nephrectomy and 24.71% 1 month 
later for the robotic assisted live donor nephrectomy patients and 26.97% at 5 
days and 22.82% after 1 month for laparoscopic donors. The laparoscopic 
group reached a peak in estimated creatinine clearance (74.7±27.4 ml/min) on 
the seventh post-operative day, while the robotic assisted nephrectomized 
patients achieved maximal estimated creatinine clearance (69.8±15.2 ml/min) 
(P=NS) on the fourth post-operative day (P=NS). 
 
Post-operative courses for transplant recipients (Table 5) 
Cold ischemia times were not significantly longer among the robotic assisted 
live donor recipients,. Each of the transplanted kidneys functioned correctly 
following surgery and none of the recipients required posttransplant dialysis. 
According to the CCR2 values, graft function improved more rapidly in the first 2 
days after transplantation in robotic assisted live donor group, however, the 
mean estimated creatinine clearances at day 5 showed no differences between 
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robotic assisted live donor and laparoscopic live donor recipients. In addition, no 
thrombotic complications were observed, even in the case of the right donor 
kidney. 
 
Table 5: Renal allograft outcomes. 
 
  Robotic 
Assisted 
(n=2) 
 Laparoscopic 
(n=20) 
 P value 
       
Cold ischemia time (min)  49.6 ±18.2  52.4 ±16.2  NS 
Ureteral complications  0  0  - 
Vascular thrombosis  0  0  - 
Pyelonephritis  0  0  - 
Sepsis related allograft dysfunction  0  0  - 
Delayed graft function  0  0  - 
CRR2 (%) = (Cr1 –Cr2) x 100/Cr1  42.6 ±15.1  32.6 ±13.9  0.01 
Day 5 creatinine clearance (ml/min)  62.2 ±17.6  58.2 ±26.7  NS 
     
Cr1 and Cr2, serum creatinine values on post-transplantation day 1 and day 2 
 
 
ROBOTIC ASSISTED KIDNEY TRANSPLANTATION 
After removal of laparoscopic bulldogs, kidney revascularization was prompt 
and homogeneous. No bleeding was noted, no additional stitches were placed, 
and urine production started immediately. 
Warm ischemia time was 51 and 38 min respectively. The uretero-vesical 
anastomosis was fashioned through the suprapubic incision using standard 
technique (Gregoir-Lich extravesical anastomosis). Before closure of the 
Pfannenstiel incision, the graft was covered by cecum and pelvic peritoneum 
thus making it a retroperitoneal graft. Total operative time was 154 and 138 min. 
 
Postoperative course 
Postoperative course was uneventful and the kidney functioned immediately. 
Serum creatinine reached 1.4 and 1.5 mg/dl (normal value 0.5–0.9) on 
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postoperative day 10, respectively. The day after the transplant, the patients 
were mobilized and started on oral intake. Pain was described as minimal, and 
no analgesic was required beyond 48 h after surgery. The patients were 
discharged on postoperative day 10. At the longest follow-up of 6 and 2 months, 
they have not been readmitted and renal function remains optimal (serum 
creatinine 1.4  and 1.6 mg/dl, respectively). 
 
 
ROBOTIC ASSISTED PANCREAS TRANSPLANTATION 
Cold ischemia time was 8 hrs and 52 min for the first pancreas graft, 5 hrs and 
35 min for the second, and 7 hrs and 35 min for the third. Cold ischemia time for 
the kidney graft was 8 hrs and 25 min. 
The pancreas after kidney transplant took overall 3 hours. The simultaneous 
pancreas-kidney transplantation took 8 hours. The pancreas transplant alone 
took 5 hours. In all recipients pancreas transplantation was carried out with 
ease.  
Warm ischemia, measured from the moment in which each graft was inserted 
into the abdomen to the time of reperfusion, was 28 minutes for the first 
pancreas, 30 minutes for the second pancreas, 35 minutes for the kidney, and 
33 minutes for the third pancreas. All grafts were reperfused immediately and 
homogeneously. No bleeding requiring additional suture was noted from 
vascular anastomosis. Hemorrhage requiring intervention occurred in the third 
pancreas graft at the level of mesenteric root and at the back of the pancreatic 
head. Bleeding was easily controlled by selective suture ligation using 4-0 and 
5-0 polypropylene. Overall, blood loss was negligible in the first recipient, 200 
ml in the second, and 300 ml in the third. 
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Each recipient became euglycemic soon after graft reperfusion. Figure 7 
summarizes the course of serum concentration of pancreatic enzymes checked 
daily during the post-transplant course. 
 
Figure 7: Course of pancreatic enzymes in the first post-transplant week. 
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Kidney transplantation also progressed smoothly. Urine production started 
immediately. 
The post-operative course of all patients was uneventful. Morphine was 
administered during the first post-transplant day, and no analgesic was required 
48 h after surgery. Recipients were out of bed on the first post-transplant day, 
and were able to stand and walk alone by post-transplant day two. Nasogastric 
tube was removed on the first post-transplant day in all patients. Recipient 2 
and 3 were able to tolerate a full diet by post-transplant day 4. Recipient 1, 
instead, had a slower recovery of gastrointestinal function, presumably because 
of severe background autonomic neuropathy. She was able to tolerate a full diet 
only on post-transplant day 10. Recipients were discharged from the hospital on 
day 33, 23, and 21 respectively. 
At the longest follow-up of 8, 6, and 3 months, respectively, all recipients are 
doing well and are fully insulin-independent. Renal function is also normal in 
each of them. 
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Discussion 
 
ROBOTIC ASSISTED LIVING DONOR NEPHRECTOMY 
The results of this study address the technical feasibility and the safety of 
robotic assisted live donor nephrectomies, as an alternative to the commonly 
used laparoscopic procedures, in the hands of experienced surgeons. It is 
noteworthy that the donors at our facility were not randomized to either form of 
surgery as all chose the robot-assisted technique. That being the case, 
comparisons between patient demographic data show striking similarities 
between the robotica assisted and laparoscopic groups. There were no fatalities 
resulting from either procedure and postoperative complications were minor 
among the two donor groups. Potential complications associated with open 
nephrectomy, such as pneumothorax or long-term wound problems (1), were 
not observed following the use of the laparoscopic or the robotic assisted 
approach, which both use short incisions and minimize cosmetic defects. The 
postoperative hospital stays were longer than those reported for the United 
States. This point can be explained by the health system in Italy. Nevertheless, 
as previously reported (2,3,7), it was observed that patients treated by 
conventional surgery are hospitalized for longer periods than those treated 
using a laparoscopic approach. Significantly, It was found that hospitalization 
periods were reduced by 50% in robotic assisted live donor group. This may 
prove to be financially advantageous in the future and lead to a lower risk of 
nosocomial infections in such patients. Laparoscopic approaches in surgical 
procedures, whilst offering many benefits, are associated with potentially life-
threatening complications that are usually not seen with the traditional ‘open’ 
approach. Specifically, laparoscopy may induce unique complications related to 
the creation of pneumoperitoneum, patient positioning, the longer duration of 
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the operation and surgical instrumentation (42, 43). In our patients, however, 
each step of the robotic assisted live donor nephrectomy procedure was 
successfully performed, without the need to revert to an open procedure. In 
addition, none of robotic assisted live donor patients experienced bleeding, 
which is the most threatening complication that has been described for 
laparoscopic procedures (4, 43–45). Furthermore, none of the donors in our 
robotic assisted live donor initial experience suffered an overt bowel injury, 
which is another intra-operative complication reported for laparoscopic surgery 
(44). The increased operative times for robotic assisted nephrectomies also did 
not lead to adverse events in the donors, such as rhabdomyolysis (46), or 
cardiovascular and pulmonary complications associated with prolonged 
pneumoperitoneum (43). Elevated intra-abdominal pressures may cause 
venous compression and reduce femoral vein flow velocity, and may be 
because intra-abdominal pressure was always kept near 12 mmHg, none of our 
patients did develop a deep vein thrombosis following laparoscopic surgery. 
The production of pneumoperitoneum can also decrease renal blood flow and 
clinical and experimental studies have previously reported a transient and self-
limiting oliguria after laparoscopy in patients with normal renal function (47). 
This phenomenon was not observed, however, in the donors undergoing robotic 
assisted or laparoscopic live donor nephrectomy at Pisa transplant centre, and 
we found that serum creatinine levels increased in a comparable manner in 
both the robotic assisted and laparoscopic groups. Amongst our recipient 
patients, there was no evidence to show that a robotic assisted live donor 
nephrectomy adversely affects allograft function. For laparoscopic donor kidney 
transplants, there are controversial data in the literature concerning early graft 
function, in which some investigators have found no significant differences 
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when comparing laparoscopic and open kidney grafts (44). In contrast to this 
evidence, a survey of US transplant centres revealed significantly slower early 
post-transplant graft function in laparoscopic donor kidney graft recipients, with 
no differences in serum creatinine levels at later time points (48), and similar 
results have been reported by others (49, 50). At Pisa transplant centre, 
however, initial graft survival and function rates, after robot-assisted 
laparoscopic procurement, compare very favourably with our laparoscopic 
control subjects. None of our patients required dialysis within the first week of 
transplantation and we observed no incidences of delayed graft function, 
assessed by CRR2 measurements. CRR2 values (51) were used as they 
enable clinicians to consider the factors that influence early graft functions, such 
as components of donation, preservation variables and recipients variables, 
rather than immune responses, which usually impact upon the transplant 
recipient at a later date. In addition, CRR2 has been proven to correlate well 
with graft function during the first year (52). This is an important consideration, 
as laparoscopic approaches entail increased intra-abdominal pressure and also 
a traumatic removal of the organ through a Pfannenstiel incision, also if it does 
not necessitate longer mean warm renal ischaemia times than robotic assisted 
live donor nephrectomies (84.3 ±16.2 seconds vs 92.4  ±12.2 seconds in this 
series).  
We consider it to be unlikely, however, that warm ischaemia times will drop 
much below 2 min using current techniques. In their experience with robotic 
assisted live donor nephrectomies, Horgan et al. (16) reported short warm renal 
ischemia times, ranging between 70 and 95 s.. The excessive manipulation and 
prolonged extraction of the kidney, during robot-assisted laparoscopic surgery, 
could lead to ischaemia-reperfusion injury and hamper organ function recovery. 
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In an experimental renal transplantation study, Yilmaz et al. (53) reported that 
prolonged ischaemia times induce intimal proliferation, vascular obliteration, 
glomerular sclerosis and increase the mesangial matrix. The eventual sclerotic 
destruction of glomeruli cannot yet be evaluated. Moreover, several 
laparoscopic urologists have observed a higher incidence of ureteral necrosis, 
or late ureteral stricture requiring operative repair, in comparison to 
laparoscopic live-donor nephrectomy recipients and open nephrectomy 
recipients (54). These lesions, which are thought to be due to impaired 
vascularity of the ureter, have been attributed to suboptimal mobilization and 
visualization of donor kidneys during the laparoscopic approach. In robotic 
assisted live donor group, however, no ureteral complications of vascular origin 
were observed in the recipients. It seems clear that, in addition to thorough 
preoperative imaging for evidence of aberrant vessels and a careful patient 
selection protocol, the training and experience of the surgeon, in addition to 
proper perioperative management of fluid and electrolyte balance, have greatly 
influenced the low rate of postoperative complications that we observed. 
Increased experience of laparoscopic procedures and also of transplantation 
surgery is well known to decrease the incidence of such complications (43). It 
must be noted that robotic assistance has been recognized to improve 
laparoscopic training and skill acquisition, and the low levels of morbidity 
observed robotic assisted live donor nephrectomy group is partly attributable to 
this robotic assistance. The three-dimensional vision of the robotic assistance 
also enhances the ability of the surgeon to perform delicate endoscopic 
manoeuvres, such as dissection or precise laparoscopic suturing. Surgeon 
fatigue and tremor levels during robotic suturing are also reduced, when 
compared with conventional laparoscopic intracorporeal methods. Dissection of 
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the ureter is also facilitated, avoiding excessive stripping. Finally, robot-assisted 
donor nephrectomy may minimize intra-operative complications by allowing 
surgeons to dissect rapidly and efficiently and to control problematic bleeding  
and lymphatic leaks more easily and efficiently (6). 
 
ROBOTIC ASSISTED KIDNEY TRANSPLANTATION 
Surgical robotics is a refinement of classic laparoscopy. The only current 
available system, the dVss, is not a classical robot, in the narrower sense of the 
word, but rather an electromechanical surgical actuator faithfully translating 
movements of surgeon’s hands into wristed instrument actions (20). As such, 
the dVss should enhance surgeon’s ability to accomplish complex laparoscopic 
operations requiring fine dissection and microsuturing. On the other hand, the 
greatest limitations of the dVss are high cost and lack of haptic feed-back. Other 
drawbacks are risk of technical failure, loss of direct contact between surgeon 
and patient, and poor adaptability to multiquadrant surgery (20). The high cost 
of the dVss is a significant problem that has probably limited the diffusion of this 
new technology. However, like other computer-driven technologies, costs are 
expected to drop over time, especially when the patent of ‘‘remote center-of-
motion robot for surgery’’ (US patent number: 5397323; Issue date: March 14, 
1995) will expire (on October 30, 2012) and competitors of Intuitive Surgical will 
have a chance to propose alternative systems. Lack of haptic feed-back is a 
further main drawback of current dVss. Theoretically, it could lead to an 
increased risk of inadvertent tissue injury but, to date, robotically performed 
operations have not been associated with higher clinical complication rates than 
their standard laparoscopic or open counterparts (20). On the other hand, 
reduction in suture strength is known to occur following robotic needle driver 
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manipulation (55, 56). While research on haptic sensors is ongoing (57-59), 
improved visual clues seem to act as a substitute for haptic feedback (59, 60). 
No device or technology is impervious to malfunction. The dVss is no exception 
to this rule. Current systems, however, are designed to minimize the deleterious 
effects of such failures on patients thanks to system redundancy features (20). 
The dVss can incur into recoverable and nonrecoverable faults. Only in the 
latter instance, the robotic procedure has to be aborted and/or there may be a 
real hazard on patient safety. In a series of 725 radical prostatectomies, the 
mean rate of recoverable and nonrecoverable faults per procedure was 0.21 
and 0.05, respectively. Interestingly, all nonrecoverable faults occurred before 
the beginning of the operation resulting in rescheduling of surgery (61). Loss of 
direct contact between surgeon and patient requires adaptation and improved 
coordination with the assistant surgeon who, instead, maintains a direct contact 
with the patient. This process requires a learning curve. Paradoxically, this 
limitation of current dVss may also have positive implications. Lack of direct 
interaction between surgeon and patient could reduce the risk of disease 
transmission, especially in kidney transplant recipients in whom there is a high 
prevalence of hepatitis infection. Overall, it would seem that the dVss could be 
used for kidney transplantation under well-controlled, investigational conditions. 
The first use of the dVss for kidney transplantation was reported by Hoznek et 
al. in 2002. Iliac vessels, however, were dissected through a standard oblique 
incision and the dVss was used only to complete the anastomoses (62). The 
first fully laparoscopic kidney transplantation using a dVss was reported by 
Giulianotti et al. (Chicago, IL, USA), early past year (63), although the first world 
case was performed by Geffner at the Saint Barnabas Medical Center (New 
Jersey, USA) in January 2009 (unpublished data). As of June 25, 2010, a total 
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of 25 robotic kidney transplantations had been performed in the USA, eight at 
the University of Illinois and 16 at Saint Barnabas Medical Center 
(Communication at 5th International Conference: ‘‘Living donor abdominal 
organ transplantation: state of the art.’’ June 25–26, 2010; Florence, Italy); to 
our knowledge, the cases described in this study are the first performed in 
Europe. The technique that it was applied differs substantially from that used in 
Chicago (63) and New Jersey. 
At the University of Illinois, Giulianotti et al. decided to adopt a hand-assisted 
technique making the incision in the periumbelical area and placing the graft 
intraperitoneally (63). Regarding the site of incision, a periumbelical incision is 
known to carry a higher risk of incisional hernia as compared with the bikini type 
incision it was adopted in these initial cases. Furthermore, a suprapubic incision 
allows direct performance of uretero-vescical anastomosis. Although this 
anastomosis can easily be constructed using the dVss, it requires repositioning 
of the robot (63) and prolongs the period during which the freshly revascularized 
graft is exposed to the detrimental effects of pneumoperitoneum (64). Hand 
assistance, easier through a periumbelical incision, could facilitate some 
operative steps, such as handling the graft during performance of vascular 
anastomoses, could improve exposure especially in obese recipient, and could 
be useful in case of sudden hemorrhage. However, with all the limitations of 
comparisons made between single case descriptions, warm ischemia period  in 
the cases of the study was identical to the one reported by the Chicago group. 
Further experience will clarify which incision is more suitable. Perhaps, the 
periumbelical incision will eventually be preferred in obese patients and the 
suprapubic incision be reserved to thinner recipients. Moreover Giulianotti et al. 
decided to place their kidney graft intraperitoneally. Although grafts placed in 
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this location are known to work efficiently, this option is not routinely adopted in 
conventional kidney transplantation. Intraperitoneal renal graft placement may 
actually be associated with unique complications, such as paratransplant hernia 
(65) and renal pedicle torsion (66). 
The technique used at the Saint Barnabas Medical Center has not been 
published yet, but we have learned of it directly from Dr. Geffner at the 5th 
International Conference: ‘‘Living donor abdominal organ transplantation: state 
of the art.’’ (June 25–26, 2010; Florence, Italy). Dr. Geffner places the kidney 
graft extraperitoneally, through a small incision made along the line that would 
be followed in case of conventional kidney transplantation. A working space is 
hence created, using the same technique employed in retroperitoneoscopic 
nephrectomy, and the anastomoses are performed robotically. At the end, the 
graft lies in the classic retroperitoneal location. 
The technique that it was  adopted in the cases of the study, which might be 
identified as ‘‘hybrid’’, employs a transperitoneal approach, but eventually 
leaves the graft in the retroperitoneum. 
In our view, working transperitoneally avoids the traditional disadvantages of 
retroperitoneoscopy, such as limited working space, ease collapse during 
suction, and blurred vision, while maintaining the advantage of eventual graft 
placement in a retroperitoneal pocket. The most prominent advantage of 
Geffner’s incision is that in case of conversion to open surgery, there would be 
no additional incision. Of course, the periumbelical incision used by Giulianotti 
et al. (63) should be extended significantly to gain full access to iliac vessels. 
Prolonging our small transverse suprapubic incision, toward the iliac fossa 
where the kidney is being transplanted, would result in a ‘‘hockey stick’’ incision, 
probably only a bit larger than the one performed under standard conditions. 
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Minimally invasive kidney transplantation might require more time to complete 
vascular anastomoses thus prolonging second warm ischemia time and 
possibly resulting in higher incidence of delayed graft function (67). It is indeed 
known that kidney temperature increases according to a logarithmic curve and 
at a speed of 0.48 °C/min. Kidney temperature at th e time of revascularization 
depends on anastomotic time and is inversely proportional to kidney weight 
(68). A prerevascularization graft temperature ≤ 15 °C is associated with 
reduced incidence of acute tubular necrosis (67). Topical graft cooling may slow 
the rate of graft rewarming (67), but is impractical to use during laparoscopic 
kidney transplantation, as cold irrigation would blur the vision of the vessels to 
be anastomosed and would require concurrent suction, decreasing the level of 
pneumoperitoneum. The use of a cooling pocket (69, 70) might be 
advantageous. However, the ideal laparoscopic cooling pocket should be 
friendly to use. To our knowledge, none of the described laparoscopic devices 
(71, 72) has been tested enough as to prove its efficacy and ease of use. On 
the other hand, the yet limited experience with kidney transplantations through 
minimal skin incision (73-75), sharing with laparoscopic kidney transplants the 
issue of graft rewarming, do not demonstrate a detrimental effect on kidney 
function. The decision to avoid additional renal graft cooling during robotic 
transplantation was based on all these considerations. The consequences of 
progressive graft rewarming occurring during minimally invasive kidney 
transplantation cannot be defined at the moment. We anticipate that this issue 
will be debated extensively and will provide new impetus to research. 
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ROBOTIC ASSISTED PANCREAS TRANSPLANTATION 
The high incidence of surgical complications is among the major disincentives 
to pancreas transplantation, despite the potentially unlimited pool of candidate 
recipients (76). Islet transplantation, the only possible alternative to pancreas 
transplantation, was indeed conceived and pursued to achieve beta-cell 
replacement with lower morbidity, but it has not achieved the expected results 
yet (24). 
In the last two decades, laparoscopy was probably the greatest innovation in 
abdominal surgery. The advantages of this approach were so evident that it 
quickly became the standard for many operations. Refinements in surgical 
techniques and advancement in equipments currently permit complex 
operations to be safely performed laparoscopically, especially when there is 
little need for multiple intracorporeal reconstructions (77, 78). In laparoscopy, 
fine sutures are demanding because of :  
1) loss of hand-eye coordination; 
2) use of long instruments with only four degrees of freedom, amplifying 
natural surgeon’s tremor and carrying a fulcrum effect; 
3) poor ergonomy leading to surgeon’s fatigue (35). 
The dVss is a computer-assisted electromechanical device allowing a remote 
surgeon to manipulate tissues, handling electromechanical devices and 
throwing microsutures through laparoscopic ports. As compared with 
conventional laparoscopy, the dVss offers 3D high-definition view, including 10x 
to 15x magnification and restoring hand-eye coordination, employs wristed 
instruments with seven degrees of freedom, and tracks surgeon’s movements 
1,300 times per second, providing for tremor filtration and scaled motion. 
Surgeon power is further enhanced by driving the binocular endoscope, 
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providing steady view, and by toggling among three operative arms. These 
technology addenda significantly improve surgeon ability to operate within deep 
and narrow spaces, especially when fine dissection and microsuturing are 
required. 
The already cited greatest limitations of current dVss are high cost and lack of 
haptic feed-back. Other drawbacks are risk of technical failure, loss of direct 
contact between surgeon and patient, and poor adaptability to multiquadrant 
surgery (32). Lack of haptic feed-back is the reason why in this study was used 
expanded polytetrafluoroethylene instead of polypropylene for vascular 
anastomosis. There is indeed a good amount of experimental evidence that 
repetitive needle driver manipulations weaken suture materials. The maximal 
failure force of monofilaments is reduced by 35% as compared with 3% for 
braided sutures (79). In particular, expanded polytetrafluoroethylene shows no 
loss in strength after repetitive robotic manipulations while polypropylene is 
weakened after three robotic manipulations at the same point (80). 
We have recently shown that kidney transplantation is feasible laparoscopically 
under robotic assistance (36). A similar experience was reported from the 
United States (35). Based on this background we speculated that a pancreas 
graft could be transplanted laparoscopically as well. Indeed, pancreas 
transplantation, alike kidney grafting, requires only one arterial and one venous 
anastomosis. In the technique that we elected to employ, which is a 
modification of the one that we have previously described (39), the pancreas 
lies on the right retroperitoneal space over the psoas muscle and behind the 
right colon. This position is similar to the one in which we had placed the grafted 
kidney during laparoscopic robot-assisted renal transplantation (36). 
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Beyond technical facilities, dVss provides a wide set of advantages over 
laparoscopic surgery: 
1) The ability of dVss to work within narrow spaces makes it possible to 
safely construct vascular anastomosis with minimal vessels exposure. 
This could be advantageous in patients with limited vascular access and 
could contribute to reduce incidence and severity of perigraft fluid 
collections. 
2) Reduced tissue handling results in reduced activation of coagulation 
systems (81). This is likely the reason why robotic surgery has been 
associated with a reduced rate of peripheral vein thrombosis than 
conventional laparoscopic surgery (82, 83). Graft thrombosis is the 
leading cause of morbidity and early graft failure after pancreas 
transplantation. A reduced activation of systemic coagulation is hence 
expected to also reduce incidence of graft thrombosis and lead to better 
graft survival. This hypothesis requires anyway confirmation in larger 
case series. 
3) Laparoscopic surgery has been associated with a reduced 
proinflammatory response (84) and with a reduced immune suppression 
(85). Since the length of surgical incisions is clearly reduced in robotic 
versus conventional laparoscopic surgery, the rate of immune 
suppression, and consequent wound infections, might be further 
reduced. From the point of view of anticipated benefits to the patients, 
perhaps no other recipient population could expect greater advantage 
from minimally-invasive transplantation than diabetics, whose post-
transplant course is typically plagued by multiple surgical complications.  
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4) Duration and severity of paralytic ileus should also be reduced, since 
intestines are not manipulated. 
Creation of the large vascular anastomoses required in pancreas 
transplantation is not an issue using the dVss. However, since the graft cannot 
be cooled during robotic suturing it is expected to rewarm progressively, instead 
of suddenly as in the open operation. We were not able to collect information on 
core pancreas temperature during our robotic transplantations. Experience with 
pancreas transplantation after cardiac death shows that warm ischemic times 
between 30 and 45 minutes have no detrimental effect on pancreas function 
both short and long term (80). It is however reasonable to anticipate that 
exceedingly long anastomotic times could result in harmful warm ischemia to 
the delicate pancreas graft. Our experience first shows that, in properly selected 
recipients, robotic anastomotic time is reasonably short. The course of 
pancreatic enzymes in the first post-transplant week (Figure 7) was indeed not 
dissimilar to the one usually seen after conventional whole pancreas 
transplantation (37). However, should anastomotic time become too long, or in 
case of surgical misadventure, the small working incision placed along the 
midline could be quickly extended to allow immediate control of the entire 
abdomen (79). 
Control of bleeding could be an issue, especially in case of multiple bleeding 
sites, and could eventually require manipulation of the freshly revascularized 
pancreas graft. Since current dVss lacks haptic feedback, and excessive 
suction could lead to collapse of pneumoperitoneum, we decided to minimize 
the risk of diffuse bleeding by securing hemostasis in the donor. Admittedly, this 
requires that graft procurement is managed by an experienced surgeon and that 
organization of donor operation permits this approach. 
 45
Conclusion 
 
In conclusion, although the patient sample size in this study is small, the 
preliminary results with the robot assisted laparoscopic approach for donor 
nephrectomy are promising. Robot assisted living donor nephrectomy is very 
challenging from a technical standpoint, but can be performed safely. In our 
experience, this has been achieved without any deleterious effect upon donor 
outcome. Initial graft survival and function rates appear to be very similar to the 
data from laparoscopic donor nephrectomy, but longer follow-ups will be 
necessary to confirm these observations. If these rates are reproducible, robot 
assisted living donor nephrectomy may improve the willingness of individuals to 
donate kidneys and thus expand the potential pool of organ donors. 
On the other side the initial experience with robot assisted kidney 
transplantation confirms that kidney transplant can be performed 
laparoscopically in selected recipients and under optimal operative conditions. 
Overall, including the cases of this study, there have been only three 
descriptions of laparoscopic kidney transplantation. It is likely that these 
embryonic experiences will foster a debate in the transplant community. 
With this study has been also shown that pancreas transplantation is feasible 
laparoscopically using robotic assistance. Should this approach prove to be 
safe and effective in larger series, it could become an alternative to 
conventional transplantation whenever organization and logistics of donor and 
recipient operation permit to do so. 
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Tables 
 
Table 1: Summary of donor characteristics. 
 
  Donor 1 
(for recipient 1) 
 Donor 2 
(for recipient 2) 
 Donor 3 
(for recipient 3) 
       
Age  48 years  16 years  25 years 
Sex  Female  Male  Female 
Body Mass Index  20.9 Kg/m
2
  20.8 Kg/m
2
  22.5 Kg/m
2
 
Waist circumeference  83 cm  78 cm  72 cm 
       
Cause of death  Cerebrovascular 
accident 
 Trauma  Trauma 
ICU stay  11 days  3 days  2 days 
       
Cardiac arrest  Yes  No  No 
Duration of cardiac 
arrest 
 20 min  -  - 
Hypotension at 
procurement 
 No  No  No 
Vasopressors  Yes  Yes  No 
 Noradrenaline  Yes  Yes  No 
 Dopamine  Yes  No  No 
       
CMV matching 
(donor/recipient) 
 Positive/Positive  Positive/Positive  Positive/Positive 
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Table 2: Summary of recipient characteristics. 
 
  Recipient 1  Recipient 2  Recipient 3 
       
Type of  transplant  Pancreas after 
kidney 
 Simultaneous 
pancreas and 
kidney 
 Pancreas 
alone 
Age  43 years  24 years  53 years 
Sex  Female  Male  Female 
Ethnicity  Caucasian  Caucasian  Caucasian 
Body Mass Index  26.4 Kg/m
2
  23.7 Kg/m
2
  20.8 Kg/m
2
 
       
Duration of diabetes  18 years  20 years  28 years 
Serum C peptide  0.28 ng/mL  0.33 ng/mL  0.22 ng/mL 
Daily insulin dose  32 UI  50 UI  35 UI 
Glycated hemoglobin  10.5%  10.8%  7.8 % 
Anti-IA2 Ab (≤ 0.75)  0.70  0.68  0.96 
Anti-GAD Ab (≤ 0.90)  0.25  0.35  0.12 
       
Diabetic nephropathy  Previous renal 
transplant 
 Chronic dyalisis  No 
Retinopathy   Proliferative  Proliferative  Proliferative 
Autonomic neuropathy  Severe  Mild  Severe 
Unawareness 
hypoglycemia 
 No  No  Yes 
       
HLA class I Ab (luminex)  10%  Negative  Negative 
HLA class II Ab (luminex)  Negative  Negative  Negative 
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Table 3: Summary of living donor and recipient demographics. 
 
  Robotic Assisted  Laparoscopic  P value 
       
Donor (n)  2  20  - 
    Mean Age (years – dev std)  60,0 ±7,1  54,3 ±7,7  NS 
    Male/Female (n)  1 / 1  8 / 12  NS 
    Mean BMI (Kg/m
2
)  25,6 ±2,5  24,7 ±2,8  NS 
    Relation to the recipient       
        Sibling  1  2  - 
        Parent  0  11  - 
        Other relatives  0  1  - 
        Spouse  1  6  - 
    HLA mismatch (n –dev std)  3,4 ±1,1  2,1 ±2,1  NS 
Left/Right kidney (n)  1 / 1  15 / 5  NS 
Multiple arteries (%)  0  5%  NS 
       
Recipient       
    Mean Age (years)  41,3 ±8,2  43,2 ±7,9  NS 
    Male/Female (n)  1 / 1  14 /6  NS 
    Mean BMI (Kg/m
2
)  24,6 ±2,1  24,9 ±2,4  NS 
    Preemptive transplant (%)  0  20%  NS 
    Retransplant (%)  0  10%  NS 
     
 
 
 
Table 4: Intraoperative and postoperative recovery data from live donors. 
 
  Robotic 
Assisted 
(n=2) 
 Laparoscopic 
(n=20) 
 P value 
       
Left/Right kidney (n)  1 / 1  15 / 5  NS 
N° of renal arteries (% - n°)       
    1  2  19  NS 
    2  0  1  NS 
Operative time (min)  102.5 ±18.2  133.4 ±24.5  NS 
Warm ischemia time (sec)  92.4 ±12.2  84.3 ±16.2  NS 
Mean decrease in post-op Hb (g/l)  9.7 ±7.6  10.6 ±8.4  NS 
Mean length of stay (days)  4.8 ±1.8  5.8 ±2.1  NS 
Mean plasma potassium at day 1 (mEq/l)  3.8 ±0.18  4.1 ±0.5  NS 
Mean blood urea nitrogen at day 1 (g/l)  0.2 ±0.08  0.2 ±0.05  NS 
Mean ClCr0-ClCr5 (ml/min)  21.1 ±14.9  26.2 ±12.2  NS 
Mean [(ClCr0-ClCr5)/ClCr0]x100 (%)  24.4 ±15.8  27.0 ±12.4  NS 
Mean ClCr0-ClCr30 (ml/min)  25.3 ±15.1  22.1 ±12.7  NS 
Mean [(ClCr0-ClCr30)/ClCr0]x100 (%)  24.7 ±14.6  22.8 ±13.0  NS 
     
ClCr0, ClCr5 and ClCr30 = creatinine clearance at day 0, 5 and 30 after nephrectomy 
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Table 5: Renal allograft outcomes. 
 
  Robotic 
Assisted 
(n=2) 
 Laparoscopic 
(n=20) 
 P value 
       
Cold ischemia time (min)  49.6 ±18.2  52.4 ±16.2  NS 
Ureteral complications  0  0  - 
Vascular thrombosis  0  0  - 
Pyelonephritis  0  0  - 
Sepsis related allograft dysfunction  0  0  - 
Delayed graft function  0  0  - 
CRR2 (%) = (Cr1 –Cr2) x 100/Cr1  42.6 ±15.1  32.6 ±13.9  0.01 
Day 5 creatinine clearance (ml/min)  62.2 ±17.6  58.2 ±26.7  NS 
     
Cr1 and Cr2, serum creatinine values on post-transplantation day 1 and day 2 
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Figures 
 
Figure 1a: Operative position. Dotted line marks the previous Pfannestiel incision. 
 
(Figure 1b: Lap Disk and operative ports in place. Port number 2 is used by the 
assistant surgeon at the table. Port number 3 is used for the optics. Port number 4 is 
used for the right robotic arm. While the DaVinci surgical system is functioning a 
further port, used for the left robotic arm, is hel in place by the Lap Disk.. 
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Figure 1c: DaVinci surgical system docked in the operative position. 
 
 
 
Figure 1c: DaVinci surgical system docked in the operative position. 
Figure 2: (a) Common iliac vessels exposed; (b) Venotomy being made using Potts 
scissors; (c) Venous anastomosis being made using black diamond micro forceps and 
De Backey forceps; (d) Arterial anastomosis being made using black diamond forceps 
and De Backey forceps; (e) Venous anastomosis after graft reperfusion; (f) Arterial 
anastomosis after graft reperfusion. 
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Figure 3: Drawing depicting the full set of robotic instruments used for kidney 
transplantation. The central drawing, within the circle, shows the range of motion of 
wristed robotic instruments. (a) Cadiere forceps; (b) fenestrated Maryland bipolar 
forceps; (c) micro bipolar forceps (d) monopolar curved scissors; (e) large needle 
driver; (f) black diamond micro forceps; (g) De Backey forceps; (h) Potts scissors.. 
 
 
Figure 4: GelPort and trocars in place. 
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Figure 5: DaVinci Surgical System docked to the operative ports. 
 
 
 
 
 
Figure 6: (a) Venous anastomosis completed; (b) Arterial anastomosis completed; (c) 
Pancreas graft few minutes after reperfusion. 
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Figure 7: Course of pancreatic enzymes in the first post-transplant week. 
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